RE: Results7 Sep 2022 16:21
Thanks for the links. I thought that the results were as good as we could reasonably have expected- strong and accelerating sales growth, improved/ recovered gross margins, good cost control and within a whisker of break even. I was also particularly encouraged by the better than expected capacity from phase 1, which reduces the pressure on cash / capital pre profitability, and the comments that they have signed up more distribution agreements for d-cell in H1 22 than in the preceding 3 years. The lack of a positive share price reaction is a bit perplexing. Sitting here wondering whether to add again!